The Discovery of Obeticholic Acid (Ocaliva™): First-in-Class FXR Agonist-Reference-Cited by-同舟云学术

The Discovery of Obeticholic Acid (Ocaliva™): First-in-Class FXR Agonist

Published:2018-04-16 Issue: Volume: Page:197-244
ISSN:
Container-title:Successful Drug Discovery
language:
Short-container-title:

Author:

Pellicciari Roberto¹,Pruzanski Mark²,Gioiello Antimo³

Affiliation:

1. TES Pharma; Corso Vannucci 47 06121 Perugia Italy

2. Intercept Pharmaceuticals; 450 W 15th Street New York NY 10001 USA

3. University of Perugia; Department of Pharmaceutical Sciences; Via del Liceo 1 06122 Perugia Italy

Publisher

Wiley-VCH Verlag GmbH & Co. KGaA

Reference141 articles.

1. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity;Pellicciari;J. Med. Chem.,2002

2. Bile salts of vertebrates: structural variation and possible evolutionary significance;Hofmann;J. Lipid Res.,2010

3. Correlation between CMC and chromatographic index: simple and effective evaluation of the hydrophobic/hydrophilic balance of bile acids;Natalini;Anal. Bioanal. Chem.,2007

4. Derived chromatographic indices as effective tools to study the self-aggregation process of bile acids;Natalini;J. Pharm. Biomed. Anal.,2009

5. Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC;Roda;J. Lipid Res.,1990

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer drugs: where are we now?;Expert Opinion on Therapeutic Patents;2024-05-15

2. Patented Farnesoid X receptor modulators: a review (2019 – present);Expert Opinion on Therapeutic Patents;2024-02-26

3. Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor;Journal of Medicinal Chemistry;2021-12-10

4. Synthesis of 12β-Methyl-18-nor-bile Acids;ACS Omega;2021-09-14

5. Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs;Molecular Pharmacology;2020-08-06